NEURO-ONCOLOGY
For more than 30 years, UAB Neuro-Oncology has provided compassionate and comprehensive care for patients
with neurologic cancers. As a regional referral center for the diagnosis and treatment of brain tumors and
other nervous system cancers, UAB offers patients access to groundbreaking, innovative surgical techniques;
new chemotherapies, biologic, and radiation therapies; and exploratory clinical trials with the most up-to-date
treatment strategies. UAB patients receive high-quality, coordinated care provided by national and international
leaders. Our multidisciplinary team is composed of neurosurgeons, neuro-oncologists, radiation oncologists,
neuro-radiologists, advanced practice providers, patient care coordinators, rehabilitation specialists, neuro-
pathologists, neuro-ophthalmologists, and other professionals.
WHY UAB
UAB Neuro-Oncology is committed to our patients and integrally involved in each case, from the time of initial
diagnosis throughout all phases of treatment. Our team approaches neurologic cancers with a variety of new
therapies and clinical trials including targeted therapies, immunotherapy, viral and gene therapies, cancer
stem cell-targeted therapies, and others. Importantly, we also recognize the heterogeneity of tumors such as
glioblastoma and provide patients with personalized therapy.
The full UAB team of physicians and specialists provides treatment options that are available only at academic,
tertiary care cancer centers. We understand the urgency that comes with a potential brain tumor diagnosis. With
the expertise and knowledge at UAB, we create the ideal environment for diagnosis and treatment. Therefore, we
are committed to evaluating your patients within one business day, when necessary.
HIGHLIGHTS
• UAB Neuro-Oncology is recognized as one of the leading neuro-oncology programs in the nation, providing
comprehensive, multidisciplinary evaluations.
• Because our program is part of the state’s only NCI-designated Comprehensive Cancer Center, our patients
have access to the most cutting-edge cancer treatments and clinical trials available.
• We are a leading member of the Adult Brain Tumor Consortium (ABTC). Its mission is to develop more effective
treatments for malignant brain tumors. As part of this consortium, UAB is able to introduce our patients to new
forms of chemotherapy, gene therapy, biologic therapy, and novel imaging techniques.
• We conduct weekly brain tumor case conferences to review clinical, neuroradiological, and pathological data
and make consensus recommendations for treatment planning.
• Our program offers a broad portfolio of clinical trials sponsored by UAB investigators, the National Cancer
Institute, and private industry.
• Our clinical care is coordinated with neurosurgery, neuro-oncology, and radiation oncology to maximize the
patient experience.
NOTABLE CLINICAL TRIALS
UAB Neuro-Oncology is always working to improve clinical care for neurosurgical disorders through clinical trials.
Our faculty are currently conducting clinical trials in the following areas:
• Recurrent, progressive glioblastoma multiforme
• Anaplastic astrocytoma
• Pediatric brain tumor
• Canine immuno-neurotherapies
• Immunotherapy and stem cell intervention for glioma
• Oncolytic viral therapy
For more information on how to enroll your patient in active clinical trials at UAB, visit
uabmedicine.org/clinicaltrials.
6
UAB Neurosurgery Annual Report 2020